General MedicationsVIALStandard
HUMIRA
ADALIMUMAB
Standard Dose
40MG/0.8ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview HUMIRA is listed in Drugs@FDA under application 125057 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ADALIMUMAB Form and strength VIAL - 40MG/0.8ML Sponsor ABBVIE INC Submission history Latest submission status date: 2025-12-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview HUMIRA is listed in Drugs@FDA under application 125057 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ADALIMUMAB Form and strength VIAL - 40MG/0.8ML Sponsor ABBVIE INC Submission history Latest submission status date: 2025-12-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.